GNL Gut and Liver
  1. Lauren P. Jatt, Malini M. Gandhi, Rong Guo, Adam Sukhija‐Cohen, Debika Bhattacharya, Chi‐hong Tseng, Kara W. Chew. Barriers to hepatitis C direct‐acting antiviral therapy among HIV/hepatitis C virus‐coinfected persons. Journal of Gastroenterology and Hepatology 2021;36:1095
    https://doi.org/10.1111/jgh.15228
  2. Yi‐Xiang Zheng, Shu‐Juan Ma, Ying‐hui Xiong, Xue‐Gong Fan. Efficacy and safety of direct acting antiviral regimens for hepatitis C virus and human immunodeficiency virus co‐infection: systematic review and network meta‐analysis. Journal of Gastroenterology and Hepatology 2020;35:1477
    https://doi.org/10.1111/jgh.15051
  3. Dae Hyun Lim, Jae Yoon Jeong, Seongwoo Nam, Jongkyoung Choi, Hyeok Choon Kwon, Yong Bum Yoon, Yeonjae Kim, BumSik Chin. Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea. J Korean Med Sci 2021;36
    https://doi.org/10.3346/jkms.2021.36.e308
  4. Eleanor Wilson, Emily Covert, Jennifer Hoffmann, Emily Comstock, Benjamin Emmanuel, Lydia Tang, Jennifer Husson, Joel Chua, Angie Price, Poonam Mathur, Elana Rosenthal, Sarah Kattakuzhy, Henry Masur, Shyam Kottilil. A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY). Journal of Hepatology 2019;71:498
    https://doi.org/10.1016/j.jhep.2019.05.021
  5. Jui-Ting Hsu, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Wen-Wei Huang, Sheng-Yeh Tang, Kun-Feng Tsai, Li-Fu Kuo, Supratip Ghose, Jui-Che Hsu, Chih-An Shih. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users. Medicina 2022;58:436
    https://doi.org/10.3390/medicina58030436
  6. Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C. 2022.
    https://doi.org/10.5772/intechopen.83609
  7. Loredana Alessio, Lorenzo Onorato, Vincenzo Sangiovanni, Francesco Borrelli, Elio Manzillo, Vincenzo Esposito, Filomena Simeone, Salvatore Martini, Nicolina Capoluongo, Sebastiano Leone, Giovanni Di Filippo, Maurizio D'Abbraccio, Lucia Aprea, Angelo Salomone Megna, Eugenio Milano, Viviana Rizzo, Annalisa Saracino, Nicola Coppola. DAA-Based Treatment for HIV–HCV-Coinfected Patients: Analysis of Factors of Sustained Virological Response in a Real-Life Study. Antiviral Therapy 2020;25:193
    https://doi.org/10.3851/IMP3353
  8. Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. WJH 2022;14:1
    https://doi.org/10.4254/wjh.v14.i1.1
  9. Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, Eun Joo Choi. Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital. Korean J Clin Pharm 2022;32:191
    https://doi.org/10.24304/kjcp.2022.32.3.191
  10. Sergie Antoniak, Charles S Chasela, Morgan Julie Freiman, Yulia Stopolianska, Tetiana Barnard, Malini M Gandhi, Maria Liulchuk, Zhanna Tsenilova, Tretiakov Viktor, Jeri Dible, Constance Wose Kinge, Francis Akpan, Thomas Minior, Ntombi Sigwebela, Sofiane Mohamed, Matthiue Barralon, Fadzai Marange, Clint Cavenaugh, Charles Vander Horst, Svitlana Antonyak, Thembisile Xulu, Kara W Chew, Ian Sanne, Sydney Rosen. Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency V irus co‐infected patients in Ukraine . JGH Open 2022;6:894
    https://doi.org/10.1002/jgh3.12839
  11. David Rial-Crestelo, María Antonia Sepúlveda, Francisco Javier González-Gasca, Paloma Geijo-Martínez, Elisa Martínez-Alfaro, José Ramón Barberá, Miguel Yzusqui, Sonia Casallo, María García, Constanza Muñoz Hornero, Alfredo Espinosa-Gimeno, Miguel Torralba. Impact of interferon-free therapies in HIV/HCV co-infected patients on real clinical practice: results from a multicenter region-wide cohort study (2014–2018). 2021;32:279
    https://doi.org/10.1097/MEG.0000000000002012
  12. Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2021.
    https://doi.org/10.2174/9789815123432123010012
  13. Do Young Kim. Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice. Gut and Liver 2018;12:609
    https://doi.org/10.5009/gnl18418
  14. Caroline Schmidbauer, David Chromy, Victor Schmidbauer, David Bauer, Michael Apata, Dung Nguyen, Mattias Mandorfer, Benedikt Simbrunner, Armin Rieger, Florian Mayer, Ralf Schmidt, Heidemarie Holzmann, Michael Trauner, Michael Gschwantler, Thomas Reiberger. Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population. Liver Int 2020;40:787
    https://doi.org/10.1111/liv.14399
  15. Calvin Q. Pan, Vijay Gayam, Charles Rabinovich, Milana Normatov, Bazhena Fidman, Dan Wang, Pavani Garlapati. Efficacy of Direct‐Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United States. J Am Geriatr Soc 2020;68:379
    https://doi.org/10.1111/jgs.16206
  16. Suparat Khemnark, Weerawat Manosuthi. Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection. JGH Open 2023;7:157
    https://doi.org/10.1002/jgh3.12869
  17. Weiyin Lin, Xicheng Wang, Jianbo Zhang, Chunyan Wen, Wen Kang, Lin Mao, Jie Yang, Yanyun Dou, Liying Shi, Bianli Dang, Yun Lan, Hong Li, Yonghong Li, Xiejie Chen, Haolan He, Min Xu, Yaozu He, Fengyu Hu, Ruichao Lu, Weiping Cai, Linghua Li. A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China. The Lancet Regional Health - Western Pacific 2023:100749
    https://doi.org/10.1016/j.lanwpc.2023.100749
  18. A. Piekarska, E. Jabłonowska, A. Garlicki, M. Sitko, W. Mazur, J. Jaroszewicz, A. Czauz-Andrzejuk, I. Buczyńska, K. Simon, B. Lorenc, D. Dybowska, W. Halota, M. Pawłowska, B. Dobracka, H. Berak, A. Horban, M. Tudrujek-Zdunek, K. Tomasiewicz, E. Janczewska, Ł. Socha, Ł. Laurans, M. Parczewski, D. Zarębska-Michaluk, P. Pabjan, T. Belica-Wdowik, B. Baka-Ćwierz, Z. Deroń, R. Krygier, J. Klapaczyński, J. Citko, A. Berkan-Kawińska, R. Flisiak. Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study. AIDS Care 2020;32:762
    https://doi.org/10.1080/09540121.2019.1645808
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd